使用TOOKAD®可溶性制剂进行的血管靶向光动力疗法治疗局限性前列腺癌：治疗程序的标准化
Vascular-targeted photodynamic therapy with TOOKAD® Soluble in localized prostate cancer: standardization of the procedure.
作者信息
Azzouzi Abdel-Rahmene, Lebdai Souhil, Benzaghou Fawzi, Stief Christian
机构信息
Urology Department, CHU Angers, 4 rue Larrey, 49933, Angers Cedex 9, France,
出版信息
World J Urol. 2015 Jul;33(7):937-44. doi: 10.1007/s00345-015-1535-2. Epub 2015 Mar 19.
INTRODUCTION
Vascular-targeted photodynamic therapy with TOOKAD(®) Soluble is an innovative focal therapy procedure assessed in localized prostate cancer treatment.
MATERIALS AND METHODS
This mini-invasive technique destroys targeted tissues using a photosensitizer [TOOKAD(®) Soluble (WST11), STEBA Biotech] activated by laser light in the presence of oxygen. Its application for prostate cancer requires intravenous infusion of TOOKAD(®) Soluble and the illumination of the targeted area by transperineal optical fibers inserted under trans-rectal ultrasound guidance under general anesthesia.
CONCLUSION
Based on the experience gained through hundreds of procedures, we describe here the standardized technique of vascular-targeted photodynamic therapy with TOOKAD(®) Soluble defined during the phase II and III trials.
引言
使用TOOKAD(®) Soluble进行的血管靶向光动力疗法是一种用于局部前列腺癌治疗的创新性局部治疗方法。
材料与方法
这种微创技术利用在氧气存在下由激光激活的光敏剂[TOOKAD(®) Soluble（WST11），STEBA生物技术公司]破坏靶向组织。其在前列腺癌中的应用需要静脉输注TOOKAD(®) Soluble，并在全身麻醉下经直肠超声引导下经会阴插入光纤对靶向区域进行照射。
结论
基于数百例手术所积累的经验，我们在此描述在II期和III期试验中确定的使用TOOKAD(®) Soluble进行血管靶向光动力疗法的标准化技术。
Zotero 插件